| Investor | Value | Of portfolio | Shares | Change | Quarter |
|---|---|---|---|---|---|
| Third Point · Dan Loeb | $26.4M | 0.56% | 5.00M | — | Q2 2026 |
| ARK Investment Management · Cathie Wood | $14.4M | 0.09% | 2.73M | −63% | Q2 2026 |
| Renaissance Technologies | $2.6M | 0.00% | 492.39K | +3.7% | Q2 2026 |
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a SRTA trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 9, 2026 | Love Reginald LamonteDirector | Sale at price 5.75 per share. | 5.1K | $29.27K |
| Jul 29, 2026 | Lauck AndrewDirector | Stock Award(Grant) at price 0.00 per share. | 35.3K | — |
| Jul 29, 2026 | Wunsch Scott MOfficer | Stock Award(Grant) at price 0.00 per share. | 57.2K | — |
| Jul 29, 2026 | Cook William L IiiDirector | Stock Award(Grant) at price 0.00 per share. | 44.4K | — |
| Jul 29, 2026 | Wiesenthal Robert SDirector | Stock Award(Grant) at price 0.00 per share. | 50.2K | — |
| Jul 29, 2026 | Love Reginald LamonteDirector | Stock Award(Grant) at price 0.00 per share. | 37.7K | — |
| Jul 29, 2026 | Philip Edward MDirector | Stock Award(Grant) at price 0.00 per share. | 30.9K | — |
| Jul 29, 2026 | Heyburn William AChief Executive Officer | Stock Award(Grant) at price 0.00 per share. | 360.2K | — |
| Jul 29, 2026 | Tomkiel Melissa M.Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | 415.9K | — |
| Jul 29, 2026 | Cohen AmirOfficer | Stock Award(Grant) at price 0.00 per share. | 69.2K | — |
| Jun 7, 2026 | Heyburn William AChief Executive Officer | Sale at price 5.87 per share. | 31.7K | $185.91K |
| Jun 7, 2026 | Tomkiel Melissa M.Chief Executive Officer | Sale at price 5.87 per share. | 29.7K | $174.51K |
| Jun 7, 2026 | Cohen AmirOfficer | Sale at price 5.87 per share. | 4.7K | $27.32K |
| Jun 7, 2026 | Wunsch Scott MOfficer | Sale at price 5.87 per share. | 5.5K | $32.58K |
| May 21, 2026 | Cohen AmirOfficer | Sale at price 5.79 - 5.91 per share. | 50.9K | $299.44K |
| May 10, 2026 | Cohen AmirOfficer | Sale at price 5.79 per share. | 14.3K | $82.83K |
| Apr 22, 2026 | Wunsch Scott MOfficer | Stock Award(Grant) at price 0.00 per share. | 57.2K | — |
| Apr 22, 2026 | Heyburn William AChief Executive Officer | Stock Award(Grant) at price 0.00 per share. | 545.6K | — |
| Apr 22, 2026 | Tomkiel Melissa M.Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | 630.3K | — |
| Apr 22, 2026 | Cohen AmirOfficer | Stock Award(Grant) at price 0.00 per share. | 83.5K | — |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 1.5 | -12.3 | -2.3 | 20.1 | 25.7 | -16.5 | -4.7 | 12.7 | -9.7 | -11.6 | −6.1% | ||
| 2025 | -9.4 | -12.2 | -19.2 | -2.9 | 31.7 | 15.5 | -1.0 | 9.5 | 15.8 | -0.6 | -13.7 | 10.8 | +13.2% |
| 2024 | -15.6 | 6.7 | -10.4 | 11.9 | -5.6 | 15.6 | -5.2 | -5.2 | -6.1 | 22.3 | 31.8 | -10.3 | +20.4% |
| 2023 | 24.6 | 4.3 | -27.3 | -22.5 | 23.3 | 22.0 | 5.8 | -23.5 | -18.8 | -17.8 | 48.8 | 11.4 | −1.4% |
| 2022 | -30.8 | 22.7 | 13.2 | 1.4 | -20.0 | -35.3 | 24.6 | -7.1 | -21.9 | 11.7 | 9.3 | -27.2 | −59.5% |
| 2021 | 33.1 | 3.5 | -32.6 | -3.3 | -2.3 | 8.0 | -27.0 | 11.0 | 22.2 | -8.9 | -7.2 | 0.5 | −20.3% |
| 2020 | 1.7 | -0.5 | -2.8 | 0.5 | 0.3 | 2.3 | 1.3 | -1.4 | 0.9 | -1.5 | 0.7 | 11.1 | +12.7% |
| 2019 | 0.5 | +0.5% |
Buy / hold / sell counts
Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical. The company offers logistics services, such as air and ground transportation for human organs, transplant teams, and related medical materials and organ placement services; transplant clinical services, including organ recovery procedures, normothermic regional perfusion, and preservation services. It also provides other clinical services comprising cardiac perfusion services, blood management and autotransfusion services, extracorporeal membrane oxygenation services, perfusion staffing, and equipment rentals. The company was formerly known as Blade Air Mobility, Inc. and changed its name to Strata Critical Medical, Inc. in August 2025. The company was founded in 2014 and is headquartered in New York, New York.